PICO Portalanswers from OpenAlex & ORCID
Frank G. Haluska
ResearcherPublications, citations & collaboration network
Frank G. Haluska is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Frank G. Haluska have?
PICO Portalindexed works
Frank G. Haluska has 195 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frank G. Haluska have?
PICO Portalcitation count
Frank G. Haluska has 28,213 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Frank G. Haluska?
PICO Portalh-index
Frank G. Haluska has an h-index of 61 in OpenAlex.
What is the i10-index of Frank G. Haluska?
PICO Portali10-index
Frank G. Haluska has an i10-index of 125 in OpenAlex.
What is the OpenAlex record for Frank G. Haluska?
PICO Portalopenalex
The OpenAlex for Frank G. Haluska is on the source record.
What are the most-cited papers on Frank G. Haluska?
PICO Portalmost cited works
Analysis of human transcriptomes
Victor E. Velculescu, Stephen L Madden, Lin Zhang, Alex Lash, Jian Yu, Carlo Rago, Anita Lal, Clarence J. Wang, Gary A. Beaudry, Kristin M Ciriello, Brian P. Cook, Michael R. Dufault, Anne Ferguson, Yuhong Gao, Tong‐Chuan He, Heiko Hermeking, Siewleng K Hiraldo, Paul M. Hwang, Marissa A Lopez, Hilary F. Luderer, Brynna Mathews, Joseph M. Petroziello, Kornélia Polyák, Leigh Zawel, Wen Zhang, Xiaoming Zhang, Wei Zhou, Frank G. Haluska, Jin Jen, Saraswati Sukumar, Gregory M. Landes, Gregory J. Riggins, Bert Vogelstein, Kenneth W. Kinzler
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice T. Shaw, Glen J. Weiss, Meera Tugnait, Narayana I. Narasimhan, David J. Dorer, David Kerstein, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, David Ross Camidge